Piperlongumine loaded PLGA nanoparticles inhibit cancer stem-like cells through modulation of STAT3 in mammosphere model of triple negative breast cancer-Reference-Cited by-同舟云学术

Piperlongumine loaded PLGA nanoparticles inhibit cancer stem-like cells through modulation of STAT3 in mammosphere model of triple negative breast cancer

Published:2022-03 Issue: Volume:616 Page:121526
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Singh Priya,Sahoo Sanjeeb Kumar

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference61 articles.

1. PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect;Acharya;Adv. Drug Deliv. Rev.,2011

2. Doxorubicin conjugated to D-alpha-tocopheryl polyethylene glycol succinate and folic acid as a prodrug for targeted chemotherapy;Anbharasi;J. Biomed. Mater. Res. A,2010

3. Stemness in cancer: stem cells, cancer stem cells, and their microenvironment;Aponte;Stem Cells Int.,2017

4. Evaluation of curcumin loaded chitosan/PEG blended PLGA nanoparticles for effective treatment of pancreatic cancer;Arya;Biomed. Pharmacother.,2018

5. Sphere-formation assay: three-dimensional in vitro culturing of prostate cancer stem/progenitor sphere-forming cells;Bahmad;Front. Oncol.,2018

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Piperlongumine inhibits antioxidant enzymes, increases ROS levels, induces DNA damage and G2/M cell cycle arrest in breast cell lines;Journal of Toxicology and Environmental Health, Part A;2024-01-27

2. Piperlongumine based nanomedicine impairs glycolytic metabolism in triple negative breast cancer stem cells through modulation of GAPDH & FBP1;Phytomedicine;2024-01

3. A polymeric nanocarrier that eradicates breast cancer stem cells and delivers chemotherapeutic drugs;Biomaterials Research;2023-12-15

4. Recent Advances of Multifunctional PLGA Nanocarriers in the Management of Triple-Negative Breast Cancer;AAPS PharmSciTech;2023-12-14

5. Nimbolide-based nanomedicine inhibits breast cancer stem-like cells by epigenetic reprogramming of DNMTs-SFRP1-Wnt/β-catenin signaling axis;Molecular Therapy - Nucleic Acids;2023-12